More support policies for specialization and innovation are brewing. According to the data of the Ministry of Industry and Information Technology, up to now, China has cultivated a total of 14,600 "little giant" enterprises with specialization and innovation, and more than 140,000 small and medium-sized enterprises with specialization and innovation. Over 80% of the "Little Giant" enterprises are located in strategic emerging industrial chains such as integrated circuits and aerospace, and the number of enterprises in future industry-related fields such as artificial intelligence and low-altitude economy is nearly 5,000. The reporter was informed that the relevant departments will study and formulate guidance on building a mechanism to promote the development and growth of specialized and innovative small and medium-sized enterprises, issue guidance on cultivating high-quality enterprises, continue to increase support for the cultivation of specialized and innovative small and medium-sized enterprises, and promote the "expansion, quality improvement and strong chain" of specialized and innovative groups. (Economic Information Daily)More support policies for specialization and innovation are brewing. According to the data of the Ministry of Industry and Information Technology, up to now, China has cultivated a total of 14,600 "little giant" enterprises with specialization and innovation, and more than 140,000 small and medium-sized enterprises with specialization and innovation. Over 80% of the "Little Giant" enterprises are located in strategic emerging industrial chains such as integrated circuits and aerospace, and the number of enterprises in future industry-related fields such as artificial intelligence and low-altitude economy is nearly 5,000. The reporter was informed that the relevant departments will study and formulate guidance on building a mechanism to promote the development and growth of specialized and innovative small and medium-sized enterprises, issue guidance on cultivating high-quality enterprises, continue to increase support for the cultivation of specialized and innovative small and medium-sized enterprises, and promote the "expansion, quality improvement and strong chain" of specialized and innovative groups. (Economic Information Daily)Lian Ping, president of the Chief Industry Research Institute of Guangkai, believes that it is expected to reduce the RRR by about 100 basis points in 2025, releasing more than 3 trillion yuan of liquidity. Among them, there is limited room for reducing the deposit reserve ratio of small and medium-sized financial institutions, and the expected RRR reduction is about 50 basis points.
Officials said that fighting broke out between the forces of Jubaland and the federal government in Somalia.About 200 people have been killed by gang attacks on civilians in Haiti. Recently, a large-scale violence against civilians in Port-au-Prince, the capital of Haiti, has killed about 200 people, most of whom are elderly people. Witnesses said that the massacre continued.Sources: The attack on the Russian oil depot did not affect the oil transportation to Europe via Ukraine. Ukrainian industrial sources said on Wednesday that the Ukrainian attack on an oil depot in the Bryansk region of Russia at night did not affect the oil transportation to Europe via Ukraine. The Ukrainian military said on Wednesday that the warehouse was part of the "Friendship" oil export pipeline and a "fire" broke out after the air raid. The source said: "This attack has nothing to do with oil transportation because it is a facility to ensure the supply of diesel and petroleum products. Everything is going according to plan. "
Henan: Promote the research on new crystalline silicon solar cell technologies such as heterojunction and perovskite/stack. The General Office of the People's Government of Henan Province issued an implementation plan for accelerating the integration of source, grid, load and storage in Henan Province, which proposed to tackle key technical problems. Promote the research on new crystalline silicon solar cell technologies such as heterojunction and perovskite/stack, and improve the efficiency of new energy power generation. Accelerate technological breakthroughs such as core chips of power equipment and coordinated control of source and network, and improve the adaptability of power grid to new energy sources. Carry out research on key technologies of digitalization and intelligence of energy system, improve the matching degree between supply and demand of power supply and load, and solve the intermittent and unstable problems of new energy power generation. Develop a new generation of high-performance energy storage technologies such as solid-state batteries and sodium ion batteries, improve the flexible adjustment ability of the system, and solve the problem of time-space mismatch between power generation and power consumption. Accelerate research on high-precision new energy and flexible load power forecasting technology, economic optimization scheduling technology, and promote the establishment of an integrated laboratory for source, network, load and storage.Kei Ma quit Xiaomi Home Technology Co., Ltd., and Tianyancha App showed that recently, Xiaomi Home Technology Co., Ltd. underwent industrial and commercial changes, and Kei Ma stepped down as the legal representative and manager. As Peng took over, Lei Jun was changed from an executive director to a director. Xiaomi Home Technology Co., Ltd. was established in January 2017 with a registered capital of RMB 80 million. Its business scope includes communication equipment sales, computer software and hardware and auxiliary equipment wholesale, computer software and hardware and auxiliary equipment retail, shoes and hats wholesale, motorcycles and spare parts wholesale, etc. It is wholly owned by Xiaomi Communication Technology Co., Ltd. According to media reports, recently, Kei Ma, vice president of Xiaomi Group, has left his post, and the news has aroused many concerns.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.
Strategy guide
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13